Peter Hosein, MD

Our very own Dr. Peter Hosein (@PeterHoseinMD) presented "Is Pancreas Subtyping Ready for Prime Time?" at #ASCO25 in a panel discussion focused on #PancreaticCancer research findings. Learn more about our presence: Sylvester.org/ASCO2025.

Join @PeterHoseinMD tomorrow for a key discussion at #ASCO25 exploring the latest in pancreatic cancer subtyping, biomarkers and vaccine research. Learn how emerging data is shaping clinical practice and pushing precision oncology forward: loom.ly/kD8NHE8.

🧵 Pancreatic cancer researchers are on the verge of developing potentially lifesaving treatment breakthroughs, desperately needed for those patients diagnosed who face a 13% chance of surviving five years.

Hey @KlempnerSam! Precepting the @HemOncMiami fellows clinic today and dropped some #D_FLOT for the first time 😎

Bravo indeed to @ASCO - @marklewismd closing the Plenary Session was perfection!

@SylvesterCancer has a new expanded booth number 10104, located left side of the exhibit hall. Stop by to see exciting research and for potential collaborations. #ASCO25 #sarcoma @GinaDAmatoMD1 @ManuPalmerini @EmilyJonczak @SteveBialickDO @PriscilaBCMD @AditiDhirMD @DrSDNimer

#ASCO25 off to a fantastic start! Great reconnecting with mentors and @SylvesterCancer faculty, attending insightful sessions and meetings, and even sneaking in some amazing Indian food. Excited for what's ahead at @ASCO! 🍛🧠💬@GlopesMd @PeterHoseinMD @GretelTerrero @HemOncMiami

Tremendously inspiring turnout and energy @PanCAN #PurpleStride Miami. Proud to Stride alongside our @SylvesterCancer providers @GretelTerrero @tipollack @DrEmiliaMason and patients (too many to mention) towards eradicating #PancreaticCancer #WageHope #InPursuitOfYourCure

What a great day at @PanCAN PurpleStride Walks in Palm Beach and Miami! 💜🙌 As a premier sponsor of the events, our own @DrJashDatta and @PeterHoseinMD addressed participants about our shared mission to end #PancreaticCancer. Tag us to share your memories from today!…

We were thrilled to host interim CEO Damian Marron & CSO David Liberg from #CantargiaAB @cantargia🇸🇪at #DattaLab @PeterHoseinMD @SylvesterCancer to discuss mutual interest in targeting IL1RAcP signaling in #PancreaticCancer, landscape of immunotx in #pancsm & optimal trial design

New #JITC short report: Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors bit.ly/43bFMuy @jasonlukemd @champiatMD @AACRPres @PeterHoseinMD @DrHaddadRobert @AndresC27622123 @GustaveRoussy @ESMO_OPEN @DanaFarber

.@PanCAN’s Early Detection Initiative just hit a major milestone – over 8,800 participants enrolled! This study aims to determine if new-onset diabetes can help detect #pancreaticcancer earlier.

Early detection could change outcomes for patients. I’m proud of @PanCAN’s commitment to funding research that moves us closer to that goal. Learn more about this milestone and what’s next. ⬇️ pancan.org/news/pancans-e…

Join us for a PanCAN Community Conversation in Miami, FL! 💜💬 Learn about the impact of PanCAN’s work in the Miami community – and how YOU can help make a difference for those affected by hashtag#pancreaticcancer. @UMiamiHealth @SylvesterCancer @BaptistHealthSF

Honored to present our work at #GI25! Very grateful for amazing mentors - @caitlinahester @NbmerchantMD @DrJashDatta @PeterHoseinMD @GretelTerrero 💜

So proud of @DrEMDickey @SylvesterCancer @theNCI #T32 fellow for her hard work & presentation @ASCO #GI25! She has become a consummate surgeon-scientist & we are so proud of her progress CC: @UMJMHSurgery @GeisingerCwlth

Early detection is critical to increasing survival, but there is no standard test to find #pancreaticcancer early. Help @PanCAN raise awareness about this disease and the steps you can take to be proactive about your health. Learn more pancan.org/awareness #PanCANawareness

Phase 3 Trial Data Inform Advancements in Targeted Therapy for Gastric/GEJ Cancers @cmpabon @SylvesterCancer #Oncology #MedEd onclive.com/view/phase-3-t…